Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

Summary

This is a Phase 1, 2-part, open-label study. Part A will be a formulation bridging and food effect study in healthy adult subjects. Part B will be an assessment of pharmacokinetics (PK) in healthy adult Chinese subjects.

Timeline

Start

2020-10-16

Primary completion

2020-12-24

Completion

2020-12-27

Drugs

Indications